CCKAR is a biomarker for prognosis and asynchronous brain metastasis of non-small cell lung cancer

Overview of attention for article published in Frontiers in oncology, January 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 1 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 25,063 followers.

CCKAR is a biomarker for prognosis and asynchronous brain metastasis of non-small cell lung cancer https://t.co/ay4hjRtcYK

11 Mar 2023

Reply Repost Favourite

CCKAR is a biomarker for prognosis and asynchronous brain metastasis of non-small cell lung cancer https://t.co/xPHb7n0wj0 https://t.co/aMP3OmcTK0

19 Jan 2023

Reply Repost Favourite

New research: CCKAR is a biomarker for prognosis and asynchronous brain metastasis of non-small cell lung cancer: Background Non-small cell lung cancer (NSCLC) is the most common histological type of lung cancer, and brain metastasis (BM) is… https://t.co

17 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.